Last reviewed · How we verify

NCT03971630: MyVENT

Tele-monitoring of Patients With Home Mechanical Ventilation (HMV) Trough Telemedicine System (MyVENT)

Completed NA Last updated 22 November 2023
What this trial tests

NA trial testing Telemedicine in Ventilatory Failure in 42 participants. Completed in 30 June 2022.

Timeline
21 January 2021
Primary endpoint
30 June 2022
30 June 2022

Quick facts

Lead sponsorSociedad Española de Neumología y Cirugía Torácica
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment42
Start date21 January 2021
Primary completion30 June 2022
Estimated completion30 June 2022
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Sociedad Española de Neumología y Cirugía Torácica

Who can join

18 and older, any sex, with Ventilatory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to improve HMV treatment adherence using an integrated telemedicine platform (MyVENT system)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Telemedicine

Trials testing the same drug.

Other recruiting trials for Ventilatory Failure

Currently open trials in the same condition.

Other Sociedad Española de Neumología y Cirugía Torácica trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03971630.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing